托伐普坦(INN，商標(biāo)是Samsca和Jinarc)是一種水生藥物，具有選擇性、競(jìng)爭(zhēng)性加壓素受體2拮抗劑的功能，用于治療與充血性心力衰竭、肝硬化和不適當(dāng)?shù)目估騽﹉綜合征相關(guān)的低鈉血癥(低血鈉水平)奧爾蒙（SIADH）。托伐普坦于2009年5月19日被美國(guó)食品和藥物管理局(FDA)批準(zhǔn)，由大阪制藥公司以商品名Samsca銷售，在印度由MSN實(shí)驗(yàn)室有限公司以商品名Tolsama & Tolvat生產(chǎn)和銷售。
2-Methylbenzoyl chloride
Methyl 5-chloro-2-nitrobenzoate
3-Methyl-4-nitrobenzoyl chloride
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
5-Chloro-2-fluorobenzaldehyde
1-(4-Amino-2-methylbenzoyl)-7-chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one
7-Chloro-1-(2-methyl-4-nitrobenzoyl)-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one
Methyl 2-amino-5-chlorobenzoate
N-(4-(7-Chloro-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide
5-Chloro-2-nitrobenzoic acid
Ethyl 4-bromobutyrate
Ethenyl 2,2-dimethylpropanoate
Methyl 7-chloro-5-oxo-1-tosyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylate
Methyl 5-chloro-2-(4-methylphenylsulfonamido)benzoate
Methyl 5-chloro-2-((N-(4-ethoxy-4-oxobutyl)-4-methylphenyl)sulfonamido)benzoate
7-Chloro-1-tosyl-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one
